United States · FDA National Drug Code directory
FLUDEOXYGLUCOSE F-18
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 24450-647_21bdce90-ba9a-4304-876b-79a11840d532
- Product NDC
- 24450-647
- Form
- INJECTION
- Composition / generic term
- FLUDEOXYGLUCOSE F-18
- Labeler
- BRIGHAM AND WOMEN`S HOSPITAL, INC., THE
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20141030
- Source listing expiry
- 20261231
Source-listed ingredients
- FLUDEOXYGLUCOSE F-18 — 300 mCi/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 30 mL in 1 VIAL, MULTI-DOSE (24450-647-30) · 24450-647-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →